Not applicableLooking for participantsNCT07508306
What this trial is testing
Patent Blue SLN in Early Ovarian Cancer Prospective Study (FIGO I-II) Evaluating Patent Blue SLN Mapping. Injection Into IP/UO Ligaments in Situ. Goals: Assess Feasibility and Accuracy vs Standard Lymphadenectomy to Minimize Surgical Morbidity
Who this might be right for
Sentinel Lymph Node Biopsy (SLNB)Early Stage Ovarian Tumors
Faculty of Medicine of Tunis 30